Suppliers / Sichuan Gowell Pharmaceutical

Sichuan Gowell Pharmaceutical

China Updated 9 July 2026

Sichuan Gowell Pharmaceutical is an API manufacturer based in China. It holds 6 active US drug master files and one valid CEP across a filed portfolio of 6 molecules.

6
active US DMFs
1
valid CEPs
1
registered plants
0
filings across 0 regulators

Registered plants

Site FDA FEI
Meishan City, China Not on file

What they file, and where

Molecule Regulators Docs
Icosapent Ethyl US FDA 2
Iron Sucrose US FDA 1
Nusinersen US FDA 1
Omega-3-Acid Ethyl Esters 90 EDQM 1
Sodium Zirconium Cyclosilicate US FDA 1
Upadacitinib US FDA 1

Also appears on these molecule pages

Questions about Sichuan Gowell Pharmaceutical

Does Sichuan Gowell Pharmaceutical hold a US DMF or a CEP?
Sichuan Gowell Pharmaceutical holds 6 active US drug master files and 1 valid CEP. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Where does Sichuan Gowell Pharmaceutical manufacture?
1 registered site is on record, in China (Meishan City). Every site is listed on this page with the register it came from.
What does Sichuan Gowell Pharmaceutical make?
6 molecules are on record against Sichuan Gowell Pharmaceutical, including Icosapent Ethyl, Iron Sucrose, Nusinersen and Omega-3-Acid Ethyl Esters 90. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Sichuan Gowell Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability